Because symptoms are similar to those of gastroesophageal reflux disease, achalasia is often misdiagnosed, explained Eric Low, MD, MPH, gastroenterology fellow at University of California, San Diego at Digestive Disease Week 2022.
Eric Low, MD, MPH, gastroenterology fellow at University of California, San Diego, explained the clinical manifestation of ahcalsia and the challenges of diagnosing the rare condition at Digestive Disease Week 2022.
Transcript
Can you explain what achalasia is, and how it manifests clinically?
Achalasia, it's a rare esophageal motility disorder. It's characterized by impaired relaxation of the lower esophageal sphincter, so it's the sphincter that connects the esophagus to the stomach. Normally, during swallowing, when you initiate a swallow, the lower esophageal sphincter will open up and allow food to go from the esophagus into the stomach. A normal transition.
Another characteristic feature of achalasia is ineffective esophageal peristalsis. Patients with achalasia don't have the ability to normally move food down the esophagus like in normal physiology. Individuals with a achalasia unfortunately have a double whammy against normal swallowing. They can't move the food in the right direction, and then they also have to push against a tight sphincter down to the bottom of the esophagus that is hard to push against. As you can imagine, individuals and achalasia have typically dysphasia for both solids and liquids. Other common symptoms of achalasia include regurgitation, heartburn, noncardiac chest pain, and weight loss.
As a rare disorder, is there a delay in diagnosis for achalasia? What are the challenges around misdiagnosis?
Achalasia is a rare disease in general. The incidence is about 1 in 100,000 persons per year, and then the prevalence is about 10 per 100,000 persons per year. It is often misdiagnosed because there's so much overlap in symptoms with gastroesophageal reflux disease (GERD), which is very, very prevalent and has a very high incidence in the US.
There's a recent study that showed about greater than 80 million people will experience symptoms of GERD, so sometimes achalasia patients are misdiagnosed as having gastroesophageal reflux disease or GERD because of the overlap in symptoms such as heartburn, regurgitation. In order to bridge this gap and reduce the amount of time that patients spend with the symptoms or amount of time being undiagnosed with achalasia, typically patients will undergo an upper endoscopy procedure. That can often be normal, so the esophagus can look normal, and patients, again, are still misdiagnosed as having gastroesophageal reflux disease. So it is important, if they still continue to have symptoms despite being on PPI [proton-pump inhibitor] therapy, that they undergo additional evaluation with either a barium esophagram or high resolution esophageal manometry in order to diagnose their dysphasia issue.
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More